Results 281 to 290 of about 1,191,145 (307)

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

Cell, 2023
Leyuan Ma
exaly  

MR1 antigen presentation to MAIT cells and other MR1-restricted T cells

Nature Reviews Immunology, 2023
Hamish E G McWilliam, José A Villadangos   +1 more
exaly  

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Cancer Cell, 2022
Sabine Heitzeneder, Robbie G Majzner, Shaurya Dhingra   +2 more
exaly  

[Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002
carcinoembryonic antigen (CEA) was first described more than three decades ago, when its presence was demonstrated in fetal gut tissue and in tumors from gastrointestinal tract. Subsequently, CEA was detected in the circulation of patients and recognized as a serum marker for colorectal cancer.
openaire   +1 more source

Cancer Associated Antigen 19-9 (CA 19-9)

2008
openaire   +1 more source

The Use of Cancer Registry Data to Study Preoperative Carcinoembryonic Antigen Level as an Indicator of Survival in Colorectal Cancer

Ca-A Cancer Journal for Clinicians, 1989
Stephen F Sener, Joan S Chmiel
exaly  

Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors

Nature Reviews Microbiology, 2010
Clifford V Harding, W Henry Boom
exaly  

The ins and outs of MHC class II-mediated antigen processing and presentation

Nature Reviews Immunology, 2015
Paul A Roche, Kazuyuki Furuta
exaly  

Towards a systems understanding of MHC class I and MHC class II antigen presentation

Nature Reviews Immunology, 2011
Jacques Neefjes, Marlieke L M Jongsma, Oddmund Bakke   +2 more
exaly  

Detecting Tumor Antigen-Specific T Cells via Interaction-Dependent Fucosyl-Biotinylation

Cell, 2020
Zilei Liu, Jie P Li, Mingkuan Chen
exaly